<div id="readme" class="md" data-path="README.md"><article class="markdown-body entry-content container-lg" itemprop="text"><p>This program comes with absolutely no warranty. No liability is accepted for any loss and risk to public health resulting from use of this software.</p>
<p align="center">
  <a target="_blank" rel="noopener noreferrer" href="https://github.com/PharmCat/ReplicateBE.jl/blob/master/docs/img/ReplicateBE-LogoNoSpace.png"><img src="https://github.com/PharmCat/ReplicateBE.jl/raw/master/docs/img/ReplicateBE-LogoNoSpace.png" style="max-width:100%;"></a>
</p>
<p>Mixed model solution for replicate designed bioequivalence study. This can be used to obtained results with methods C (random effects with interaction), given by the EMA in <a href="https://www.ema.europa.eu/en/documents/other/31-annex-i-statistical-analysis-methods-compatible-ema-bioequivalence-guideline_en.pdf" title="EMA/582648/2016, 21 September 2016" rel="nofollow">Annex I</a>. Statistical model formed with accordance <a href="https://www.fda.gov/media/70958/download" rel="nofollow">FDA Guidance for Industry: Statistical Approaches to Establishing Bioequivalence</a>, APPENDIX F.</p>
<p><a target="_blank" rel="noopener noreferrer" href="https://github.com/PharmCat/ReplicateBE.jl/workflows/Tier%201/badge.svg"><img src="https://github.com/PharmCat/ReplicateBE.jl/workflows/Tier%201/badge.svg" alt="Tier 1" style="max-width:100%;"></a>
<a href="https://codecov.io/gh/PharmCat/ReplicateBE.jl" rel="nofollow"><img src="https://camo.githubusercontent.com/2bfd2f5363acfd46d1d7bc92efdae465fc621a96f3c14be02e8ebb8c977c04b4/68747470733a2f2f636f6465636f762e696f2f67682f506861726d4361742f5265706c696361746542452e6a6c2f6272616e63682f6d61737465722f67726170682f62616467652e737667" alt="codecov" data-canonical-src="https://codecov.io/gh/PharmCat/ReplicateBE.jl/branch/master/graph/badge.svg" style="max-width:100%;"></a>
<a href="https://pharmcat.github.io/ReplicateBE.jl/latest/" rel="nofollow"><img src="https://camo.githubusercontent.com/56f8252ba8e9d3f0b810769543f77823d2fe031ce560d4c2d69fb1fcad800383/68747470733a2f2f696d672e736869656c64732e696f2f62616467652f646f63732d6c61746573742d626c75652e737667" alt="Latest docs" data-canonical-src="https://img.shields.io/badge/docs-latest-blue.svg" style="max-width:100%;"></a>
<a href="https://doi.org/10.13140/RG.2.2.27418.39363" rel="nofollow"><img src="https://camo.githubusercontent.com/593c5ac02659dda2a2c62d1a2eade1562f8799703a1be8a23793787f818e2d62/68747470733a2f2f696d672e736869656c64732e696f2f62616467652f646f692d31302e313331343025324652472e322e322e32373431382e33393336332d626c7565" alt="doi" data-canonical-src="https://img.shields.io/badge/doi-10.13140%2FRG.2.2.27418.39363-blue" style="max-width:100%;"></a>
<a href="https://doi.org/10.5281/zenodo.3543823" rel="nofollow"><img src="https://camo.githubusercontent.com/a53df749bb6100478f87ce60267679266a4216d6af11ebbf2384f45b82e29d1a/68747470733a2f2f7a656e6f646f2e6f72672f62616467652f444f492f31302e353238312f7a656e6f646f2e333534333832332e737667" alt="DOI" data-canonical-src="https://zenodo.org/badge/DOI/10.5281/zenodo.3543823.svg" style="max-width:100%;"></a></p>
<p>Install:</p>
<div class="snippet-clipboard-content position-relative" data-snippet-clipboard-copy-content="using Pkg; Pkg.add(&quot;ReplicateBE&quot;)
"><pre><code>using Pkg; Pkg.add("ReplicateBE")
</code></pre></div>
<p>Install latest version directly:</p>
<div class="snippet-clipboard-content position-relative" data-snippet-clipboard-copy-content="using Pkg; Pkg.clone(&quot;https://github.com/PharmCat/ReplicateBE.jl.git&quot;)
"><pre><code>using Pkg; Pkg.clone("https://github.com/PharmCat/ReplicateBE.jl.git")
</code></pre></div>
<p>Using:</p>
<div class="snippet-clipboard-content position-relative" data-snippet-clipboard-copy-content="using ReplicateBE
be = ReplicateBE.rbe!(df, dvar = :var, subject = :subject, formulation = :formulation, period = :period, sequence = :sequence);
ci = confint(be, 0.1)
"><pre><code>using ReplicateBE
be = ReplicateBE.rbe!(df, dvar = :var, subject = :subject, formulation = :formulation, period = :period, sequence = :sequence);
ci = confint(be, 0.1)
</code></pre></div>
<p>Where:</p>
<ul>
<li>dvar::Symbol - dependent variable;</li>
<li>subject::Symbol - subject;</li>
<li>formulation::Symbol - formulation/drug;</li>
<li>period::Symbol - study period;</li>
<li>sequence::Symbol - sequence.</li>
</ul>
<p>How to get results?</p>
<div class="snippet-clipboard-content position-relative" data-snippet-clipboard-copy-content="#Fixed effect table:
fixed(be)

#Type III table
typeiii(be)
"><pre><code>#Fixed effect table:
fixed(be)

#Type III table
typeiii(be)
</code></pre></div>
<p>Output example:</p>
<div class="snippet-clipboard-content position-relative" data-snippet-clipboard-copy-content="Bioequivalence Linear Mixed Effect Model (status: converged)

-2REML: 329.257    REML: -164.629

Fixed effect:
───────────────────────────────────────────────────────────────────────────────────────────
Effect           Value         SE          F          DF        t           P|t|
───────────────────────────────────────────────────────────────────────────────────────────
(Intercept)      4.42158       0.119232    1375.21    68.6064   37.0838     4.02039E-47*   
sequence: 2      0.360591      0.161776    4.96821    62.0      2.22895     0.0294511*     
period: 2        0.027051      0.0533388   0.257206   122.73    0.507155    0.612956       
period: 3        -0.00625777   0.0561037   0.012441   153.634   -0.111539   0.911334       
period: 4        0.036742      0.0561037   0.428886   153.634   0.654894    0.513515       
formulation: 2   0.0643404     0.0415345   2.39966    62.0      1.54908     0.126451       
───────────────────────────────────────────────────────────────────────────────────────────
Intra-individual variance:
formulation: 1   0.108629    CVᵂ:   33.87   %   
formulation: 2   0.0783544   CVᵂ:   28.55   %

Inter-individual variance:
formulation: 1   0.377846
formulation: 2   0.421356
ρ:               0.980288   Cov: 0.391143   

Confidence intervals(90%):
formulation: 1 / formulation: 2
Ratio: 93.77, CI: 87.49 - 100.5 (%)
formulation: 2 / formulation: 1
Ratio: 106.65, CI: 99.5 - 114.3 (%)
"><pre><code>Bioequivalence Linear Mixed Effect Model (status: converged)

-2REML: 329.257    REML: -164.629

Fixed effect:
───────────────────────────────────────────────────────────────────────────────────────────
Effect           Value         SE          F          DF        t           P|t|
───────────────────────────────────────────────────────────────────────────────────────────
(Intercept)      4.42158       0.119232    1375.21    68.6064   37.0838     4.02039E-47*   
sequence: 2      0.360591      0.161776    4.96821    62.0      2.22895     0.0294511*     
period: 2        0.027051      0.0533388   0.257206   122.73    0.507155    0.612956       
period: 3        -0.00625777   0.0561037   0.012441   153.634   -0.111539   0.911334       
period: 4        0.036742      0.0561037   0.428886   153.634   0.654894    0.513515       
formulation: 2   0.0643404     0.0415345   2.39966    62.0      1.54908     0.126451       
───────────────────────────────────────────────────────────────────────────────────────────
Intra-individual variance:
formulation: 1   0.108629    CVᵂ:   33.87   %   
formulation: 2   0.0783544   CVᵂ:   28.55   %

Inter-individual variance:
formulation: 1   0.377846
formulation: 2   0.421356
ρ:               0.980288   Cov: 0.391143   

Confidence intervals(90%):
formulation: 1 / formulation: 2
Ratio: 93.77, CI: 87.49 - 100.5 (%)
formulation: 2 / formulation: 1
Ratio: 106.65, CI: 99.5 - 114.3 (%)
</code></pre></div>
<h1><a id="user-content-validation" class="anchor" aria-hidden="true" href="#validation"><svg class="octicon octicon-link" viewBox="0 0 16 16" version="1.1" width="16" height="16" aria-hidden="true"><path fill-rule="evenodd" d="M7.775 3.275a.75.75 0 001.06 1.06l1.25-1.25a2 2 0 112.83 2.83l-2.5 2.5a2 2 0 01-2.83 0 .75.75 0 00-1.06 1.06 3.5 3.5 0 004.95 0l2.5-2.5a3.5 3.5 0 00-4.95-4.95l-1.25 1.25zm-4.69 9.64a2 2 0 010-2.83l2.5-2.5a2 2 0 012.83 0 .75.75 0 001.06-1.06 3.5 3.5 0 00-4.95 0l-2.5 2.5a3.5 3.5 0 004.95 4.95l1.25-1.25a.75.75 0 00-1.06-1.06l-1.25 1.25a2 2 0 01-2.83 0z"></path></svg></a>Validation</h1>
<p>Validation information: <a href="https://pharmcat.github.io/ReplicateBE.jl/latest/testval/" rel="nofollow">here</a>, validation results you can find in <a href="https://github.com/PharmCat/ReplicateBE.jl/blob/master/validation/Validation%20results.csv">table</a>.</p>
<h1><a id="user-content-basic-methods" class="anchor" aria-hidden="true" href="#basic-methods"><svg class="octicon octicon-link" viewBox="0 0 16 16" version="1.1" width="16" height="16" aria-hidden="true"><path fill-rule="evenodd" d="M7.775 3.275a.75.75 0 001.06 1.06l1.25-1.25a2 2 0 112.83 2.83l-2.5 2.5a2 2 0 01-2.83 0 .75.75 0 00-1.06 1.06 3.5 3.5 0 004.95 0l2.5-2.5a3.5 3.5 0 00-4.95-4.95l-1.25 1.25zm-4.69 9.64a2 2 0 010-2.83l2.5-2.5a2 2 0 012.83 0 .75.75 0 001.06-1.06 3.5 3.5 0 00-4.95 0l-2.5 2.5a3.5 3.5 0 004.95 4.95l1.25-1.25a.75.75 0 00-1.06-1.06l-1.25 1.25a2 2 0 01-2.83 0z"></path></svg></a>Basic methods</h1>
<p>All API docs see <a href="https://pharmcat.github.io/ReplicateBE.jl/latest/api/" rel="nofollow">here</a>.</p>
<h1><a id="user-content-random-dataset" class="anchor" aria-hidden="true" href="#random-dataset"><svg class="octicon octicon-link" viewBox="0 0 16 16" version="1.1" width="16" height="16" aria-hidden="true"><path fill-rule="evenodd" d="M7.775 3.275a.75.75 0 001.06 1.06l1.25-1.25a2 2 0 112.83 2.83l-2.5 2.5a2 2 0 01-2.83 0 .75.75 0 00-1.06 1.06 3.5 3.5 0 004.95 0l2.5-2.5a3.5 3.5 0 00-4.95-4.95l-1.25 1.25zm-4.69 9.64a2 2 0 010-2.83l2.5-2.5a2 2 0 012.83 0 .75.75 0 001.06-1.06 3.5 3.5 0 00-4.95 0l-2.5 2.5a3.5 3.5 0 004.95 4.95l1.25-1.25a.75.75 0 00-1.06-1.06l-1.25 1.25a2 2 0 01-2.83 0z"></path></svg></a>Random Dataset</h1>
<p>Random dataset function is made for generation validation datasets and simulation data.  Description <a href="https://pharmcat.github.io/ReplicateBE.jl/latest/syntax/" rel="nofollow">here</a>.</p>
<h2><a id="user-content-structures" class="anchor" aria-hidden="true" href="#structures"><svg class="octicon octicon-link" viewBox="0 0 16 16" version="1.1" width="16" height="16" aria-hidden="true"><path fill-rule="evenodd" d="M7.775 3.275a.75.75 0 001.06 1.06l1.25-1.25a2 2 0 112.83 2.83l-2.5 2.5a2 2 0 01-2.83 0 .75.75 0 00-1.06 1.06 3.5 3.5 0 004.95 0l2.5-2.5a3.5 3.5 0 00-4.95-4.95l-1.25 1.25zm-4.69 9.64a2 2 0 010-2.83l2.5-2.5a2 2 0 012.83 0 .75.75 0 001.06-1.06 3.5 3.5 0 00-4.95 0l-2.5 2.5a3.5 3.5 0 004.95 4.95l1.25-1.25a.75.75 0 00-1.06-1.06l-1.25 1.25a2 2 0 01-2.83 0z"></path></svg></a>Structures</h2>
<p>Struct information see <a href="https://pharmcat.github.io/ReplicateBE.jl/latest/struct/" rel="nofollow">here</a>.</p>
<h2><a id="user-content-acknowledgments" class="anchor" aria-hidden="true" href="#acknowledgments"><svg class="octicon octicon-link" viewBox="0 0 16 16" version="1.1" width="16" height="16" aria-hidden="true"><path fill-rule="evenodd" d="M7.775 3.275a.75.75 0 001.06 1.06l1.25-1.25a2 2 0 112.83 2.83l-2.5 2.5a2 2 0 01-2.83 0 .75.75 0 00-1.06 1.06 3.5 3.5 0 004.95 0l2.5-2.5a3.5 3.5 0 00-4.95-4.95l-1.25 1.25zm-4.69 9.64a2 2 0 010-2.83l2.5-2.5a2 2 0 012.83 0 .75.75 0 001.06-1.06 3.5 3.5 0 00-4.95 0l-2.5 2.5a3.5 3.5 0 004.95 4.95l1.25-1.25a.75.75 0 00-1.06-1.06l-1.25 1.25a2 2 0 01-2.83 0z"></path></svg></a>Acknowledgments</h2>
<p>Best acknowledgments to D.Sc. in Physical and Mathematical Sciences Anastasia Shitova <a href="mailto:a.shitova@qayar.ru">a.shitova@qayar.ru</a> for support, datasets and testing procedures.</p>
<h2><a id="user-content-references" class="anchor" aria-hidden="true" href="#references"><svg class="octicon octicon-link" viewBox="0 0 16 16" version="1.1" width="16" height="16" aria-hidden="true"><path fill-rule="evenodd" d="M7.775 3.275a.75.75 0 001.06 1.06l1.25-1.25a2 2 0 112.83 2.83l-2.5 2.5a2 2 0 01-2.83 0 .75.75 0 00-1.06 1.06 3.5 3.5 0 004.95 0l2.5-2.5a3.5 3.5 0 00-4.95-4.95l-1.25 1.25zm-4.69 9.64a2 2 0 010-2.83l2.5-2.5a2 2 0 012.83 0 .75.75 0 001.06-1.06 3.5 3.5 0 00-4.95 0l-2.5 2.5a3.5 3.5 0 004.95 4.95l1.25-1.25a.75.75 0 00-1.06-1.06l-1.25 1.25a2 2 0 01-2.83 0z"></path></svg></a>References</h2>
<ul>
<li>FDA Guidance for Industry: Statistical Approaches to Establishing Bioequivalence, 2001</li>
<li>Fletcher, Roger (1987), Practical methods of optimization (2nd ed.), New York: John Wiley &amp; Sons, ISBN 978-0-471-91547-8</li>
<li>Giesbrecht, F. G., and Burns, J. C. (1985), "Two-Stage Analysis Based on a Mixed Model: Large-sample Asymptotic Theory and Small-Sample Simulation Results," Biometrics, 41, 853-862.</li>
<li>Gurka, Matthew. (2006). Selecting the Best Linear Mixed Model under REML. The American Statistician. 60. 19-26. 10.1198/000313006X90396.</li>
<li>Henderson, C. R., et al. “The Estimation of Environmental and Genetic Trends from Records Subject to Culling.” Biometrics, vol. 15, no. 2, 1959, pp. 192–218. JSTOR, <a href="http://www.jstor.org/stable/2527669" rel="nofollow">www.jstor.org/stable/2527669</a>.</li>
<li>Hrong-Tai Fai &amp; Cornelius (1996) Approximate F-tests of multiple degree of freedom hypotheses in generalized least squares analyses of unbalanced split-plot experiments, Journal of Statistical Computation and Simulation, 54:4, 363-378, DOI: 10.1080/00949659608811740</li>
<li>Jennrich, R., &amp; Schluchter, M. (1986). Unbalanced Repeated-Measures Models with Structured Covariance Matrices. Biometrics, 42(4), 805-820. doi:10.2307/2530695</li>
<li>Laird, Nan M., and James H. Ware. “Random-Effects Models for Longitudinal Data.” Biometrics, vol. 38, no. 4, 1982, pp. 963–974. JSTOR, <a href="http://www.jstor.org/stable/2529876" rel="nofollow">www.jstor.org/stable/2529876</a>.</li>
<li>Lindstrom &amp; J.; Bates, M. (1988). Newton—Raphson and EM Algorithms for Linear Mixed-Effects Models for Repeated-Measures Data. Journal of the American Statistical Association. 83. 1014. 10.1080/01621459.1988.10478693.</li>
<li>Mogensen et al., (2018). Optim: A mathematical optimization package for Julia. Journal of Open Source Software, 3(24), 615,doi: 10.21105/joss.00615</li>
<li>Patterson, S. D. and Jones, B. (2002), Bioequivalence and the pharmaceutical industry. Pharmaceut. Statist., 1: 83-95. doi:10.1002/pst.15</li>
<li>Revels, Jarrett &amp; Lubin, Miles &amp; Papamarkou, Theodore. (2016). Forward-Mode Automatic Differentiation in Julia.</li>
<li>Schaalje GB, McBride JB, Fellingham GW. Adequacy of approximations to distributions of test statistics in complex mixed linear models. J Agric Biol Environ Stat. 2002;7:512–24.</li>
<li>Van Peer, A. (2010), Variability and Impact on Design of Bioequivalence Studies. Basic &amp; Clinical Pharmacology &amp; Toxicology, 106: 146-153. doi:10.1111/j.1742-7843.2009.00485.x</li>
<li>Wolfinger et al., (1994) Computing gaussian likelihoods and their derivatives for general linear mixed models doi: 10.1137/0915079</li>
<li>Wright, Stephen, and Jorge Nocedal (2006) "Numerical optimization." Springer</li>
</ul>
<p>Author: Vladimir Arnautov aka PharmCat
Copyright © 2019 Vladimir Arnautov <a href="mailto:mail@pharmcat.net">mail@pharmcat.net</a></p>
</article></div>